CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Tyrosine Kinase Inhibitors Cyclin Dependent Kinase Inhibitors Serine-Threonine Kinase Inhibitors | Non Small Cell Lung Cancer | Lung Non-Squamous Non-Small Cell Cancer |
---|---|---|
bevacizumab + atezolizumab | ||
pembrolizumab | ||
pembrolizumab + abemaciclib |